Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Bexarotene · Targretin, LG-100069

Small molecule · Agonist of retinoid X receptor alpha (RXRA), retinoid X receptor beta (RXRB) and retinoid X receptor gamma (RXRG) · developed by Bausch

Approved FDA, Dec 1999
1 Registered trials

What is Bexarotene?

Bexarotene is a retinoid that selectively binds and activates retinoid X receptor subtypes (RXRα, RXRβ, RXRγ). Activated RXRs act as transcription factors regulating genes that control cellular differentiation and proliferation. It is used in cutaneous T-cell lymphoma and has been studied in parapsoriasis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Targretin, LG-100069, LGD-1069
Drug type
Small molecule
Targets
retinoid X receptor alpha (RXRA), retinoid X receptor beta (RXRB), retinoid X receptor gamma (RXRG)
Mechanism
Agonist of retinoid X receptor alpha (RXRA), retinoid X receptor beta (RXRB) and retinoid X receptor gamma (RXRG)
Pathways
nuclear receptor transcription regulation, cellular differentiation, cellular proliferation, RXR heterodimer signaling with RAR, VDR, TR and PPAR
Therapy area
Dermatology, Oncology
Developer
Bausch
In trials of
LGND
FDA status
Approved as Targretin (December 29, 1999), NDA021055 · FDA label
UNII
A61RXM4375

✅ FDA-approved uses

From the indications section of the FDA label (version of Apr 30, 2020). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00322296 Phase 2 Parapsoriasis Terminated LGND

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Parapsoriasis

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.